Kiora Pharmaceuticals Company Insiders

Kiora Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of 0.1296 % which means that it generated a profit of $0.1296 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1369 %, meaning that it created $0.1369 on every $100 dollars invested by stockholders. Kiora Pharmaceuticals' management efficiency ratios could be used to measure how well Kiora Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.68 in 2024. Return On Capital Employed is likely to rise to -0.99 in 2024. At this time, Kiora Pharmaceuticals' Other Current Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 5.6 M in 2024, whereas Total Assets are likely to drop slightly above 11.7 M in 2024. Common Stock Shares Outstanding is likely to rise to about 564.9 K in 2024, whereas Net Loss is likely to drop (15.5 M) in 2024.

Kiora Pharmaceuticals Workforce Comparison

The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (121.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $121.23.

Kiora Pharmaceuticals Insider Trading History

Kiora Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Kiora Pharmaceuticals often depends on how effective the management is. Kiora Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kiora management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kiora management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Kiora Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kiora Pharmaceuticals. Check Kiora Pharmaceuticals' Beneish M Score to see the likelihood of Kiora Pharmaceuticals' management manipulating its earnings.

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.